Company
MicroPort CardioFlow Medtech Corp
Headquarters: Shanghai, China
Employees: 451
Market Cap
HK$2.12 Billion
HKD as of July 1, 2024
US$271.9 Million
MicroPort CardioFlow Medtech Corp Categories
China Healthcare Medical DevicesChina Healthcare China Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $178.02 B |
| Stryker Corporation | $126.48 B |
| Boston Scientific Corporation | $112.32 B |
| Medtronic | $98.95 B |
| Edwards Lifesciences Corporation | $55.63 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
MicroPort CardioFlow Medtech Corporation, a medical device company, focuses on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases in the People's Republic of China. Its products include Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set, which targets aortic, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company was founded in 2010 and is headquartered in Shanghai, China. MicroPort CardioFlow Medtech Corporation is a subsidiary of Shanghai MicroPort Limited.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
MicroPort CardioFlow Medtech Corp has the following listings and related stock indices.
Stock: HKEX: 2160 wb_incandescent
Stock: FSX: 72X wb_incandescent